Pedraz, José Luis - Search Results - UAB Digital Repository of Documents

Search collections:

Sort by:	Display results:	Output format:

UAB Digital Repository of Documents	2 records found	Search took 0.00 seconds.

19 p, 4.6 MB

Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior / Revilla, Giovanna (Institut d'Investigació Biomèdica Sant Pau) ; Al Qtaish, Nuseibah (Amman Arab University) ; Caruana, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Sainz-Ramos, Myriam (Universidad del País Vasco) ; Lopez-Mendez, Tania (Universidad del País Vasco) ; Rodríguez, Francisco (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Paez-Espinosa, Verónica (Pontificia Universidad Católica del Ecuador) ; Li, Changda (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Vallverdú, Núria Fucui (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Edwards, Maria (Institut d'Investigació Biomèdica Sant Pau) ; Moral Duarte, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Pérez, José Ignacio (Institut d'Investigació Biomèdica Sant Pau) ; Escolà-Gil, Joan Carles (Institut d'Investigació Biomèdica Sant Pau) ; Pedraz, José Luis (NanoBioCel Research Group) ; Gallego, Idoia (NanoBioCel Research Group) ; Corcoy i Pla, Rosa (Institut d'Investigació Biomèdica Sant Pau) ; Céspedes, María Virtudes (Institut d'Investigació Biomèdica Sant Pau) ; Puras, Gustavo (NanoBioCel Research Group) ; Mato, Eugenia (Institut d'Investigació Biomèdica Sant Pau)
Background: Lenvatinib, a tyrosine kinase inhibitor (TKI) approved for the treatment of progressive and radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC), is associated with significant adverse effects that can be partially mitigated through the development of novel drug formulations. [...]
2023 - DOI (Digital Object Identifier)

10.3390/biom13111647
Biomolecules, Vol. 13 (november 2023)

Detailed record -

2.5 MB

Graphene oxide enhances alginate encapsulated cells viability and functionality while not affecting the foreign body response / Ciriza, Jesús (NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country, UPV/EHU) ; Saenz del Burgo, Laura (NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country, UPV/EHU) ; Gurruchaga, Haritz (NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country, UPV/EHU) ; Borràs i Serres, Francesc Enric (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Franquesa, Marcella (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Orive, Gorka (NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country, UPV/EHU) ; Hernández, Rosa Maria (NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country, UPV/EHU) ; Pedraz, José Luis (Universidad del País Vasco) ; Universitat Autònoma de Barcelona
The combination of protein-coated graphene oxide (GO) and microencapsulation technology has moved a step forward in the challenge of improving long-term alginate encapsulated cell survival and sustainable therapeutic protein release, bringing closer its translation from bench to the clinic. [...]
2018 - DOI (Digital Object Identifier)

10.1080/10717544.2018.1474966
Drug Delivery, Vol. 25 (may 2018) , p. 1147-1160

Detailed record -

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.